PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, 410008 Hunan Province, China.\', \'Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, P. R. China.\', \'Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, 110 Xiangya Road, Changsha 410078, P. R. China.\', \'Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, 110 Xiangya Road, Changsha 410078, P. R. China.\', \'National Clinical Research Center for Geriatric Disorders, 87 Xiangya Road, Changsha 410008, Hunan P.R. China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acschemneuro.0c00294
?:doi
?:hasPublicationType
?:journal
  • ACS chemical neuroscience
is ?:pmid of
?:pmid
?:pmid
  • 32485101
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.442
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all